US Stock MarketDetailed Quotes
ONPH ONCOLOGY PHARMA INC
- 0.000100
- 0.0000000.00%
15min DelayClose May 17 16:00 ET
3.80KMarket Cap0.00P/E (TTM)
0.000100High0.000100Low213Volume0.000100Open0.000100Pre Close0.02Turnover0.00%Turnover Ratio0.00P/E (Static)37.96MShares1.05000052wk High0.00P/B3.80KFloat Cap0.00000152wk Low--Dividend TTM37.96MShs Float42.780000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
ONCOLOGY PHARMA INC Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2004 | (Q2)Sep 30, 2004 | (Q1)Jun 30, 2004 | (FY)Mar 31, 2004 | (Q4)Mar 31, 2004 | (Q3)Dec 31, 2003 | (Q2)Sep 30, 2003 | (Q1)Jun 30, 2003 | (FY)Mar 31, 2003 | (Q4)Mar 31, 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | -63.99%1.18M | -89.72%94K | -81.24%139K | -41.45%421K | -41.83%527K | -10.68%3.28M | 10.79%914K | |
| Operating revenue | --0 | --0 | ---- | -63.99%1.18M | -89.72%94K | -81.24%139K | -41.45%421K | -41.83%527K | -10.68%3.28M | 10.79%914K |
| Cost of revenue | 0 | 0 | -46.04%654K | -91.19%29K | -49.34%154K | -12.55%237K | -24.03%234K | -10.75%1.21M | 8.22%329K | |
| Gross profit | 0 | 0 | -74.52%527K | -88.89%65K | -103.43%-15K | -58.93%184K | -51.00%293K | -10.63%2.07M | 12.28%585K | |
| Operating expense | -84.21%81K | -97.56%15K | -82.26%118K | -39.67%2.23M | -44.10%436K | -47.55%513K | -36.31%614K | -31.51%665K | -14.71%3.69M | -8.98%780K |
| Selling and administrative expenses | -80.24%81K | -97.07%15K | -79.19%118K | -36.42%1.85M | -27.69%363K | -48.43%410K | -36.16%512K | -30.34%567K | -18.11%2.91M | -23.71%502K |
| Research and development costs | --0 | --0 | ---- | -51.79%376K | -73.74%73K | -43.72%103K | -37.04%102K | -37.58%98K | 0.91%780K | 39.70%278K |
| Operating profit | 84.66%-81K | 96.51%-15K | 68.28%-118K | -4.68%-1.7M | -90.26%-371K | 2.40%-528K | 16.67%-430K | 0.27%-372K | 19.39%-1.63M | 41.96%-195K |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -5,900.00%-60K | 54.12%131K | 1,433.33%138K | 88.89%-1K | -5K | -101.18%-1K | 504.76%85K | 50.00%9K | ||
| Special income (charges) | --0 | --0 | -5,900.00%-60K | 54.12%131K | 1,433.33%138K | 88.89%-1K | ---5K | -101.18%-1K | 504.76%85K | 50.00%9K |
| Income before tax | ||||||||||
| Income tax | ||||||||||
| Net income | 84.66%-81K | 96.54%-15K | 52.02%-178K | -2.96%-1.57M | -26.63%-233K | 3.47%-528K | 15.10%-433K | -32.97%-371K | 22.09%-1.52M | 43.21%-184K |
| Net income continuous Operations | 84.66%-81K | 96.54%-15K | 52.02%-178K | -2.96%-1.57M | -26.63%-233K | 3.47%-528K | 15.10%-433K | -32.97%-371K | 22.09%-1.52M | 43.21%-184K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 84.66%-81K | 96.54%-15K | 52.02%-178K | -2.96%-1.57M | -26.63%-233K | 3.47%-528K | 15.10%-433K | -32.97%-371K | 22.09%-1.52M | 43.21%-184K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 84.66%-81K | 96.54%-15K | 52.02%-178K | -2.96%-1.57M | -26.63%-233K | 3.47%-528K | 15.10%-433K | -32.97%-371K | 22.09%-1.52M | 43.21%-184K |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg